模型风险评分可能低估局限性前列腺癌非洲裔美国男性的生化复发率:一项超过3000名男性的队列分析
回顾性分析2015至2021年宾夕法尼亚泌尿区域协作组中接受根治性前列腺切除术的男性,比较非洲裔美国男性(AAM)与白人男性(CM)在CAPRA、CAPRA-S及MSKCC列线图校正后的生化复发(BCR)和不良病理(AP)差异,发现AAM的BCR和AP发生率高于模型预测。
要点
- AAM的2年无BCR生存率为72.5%,低于CM的79.0%,HR为1.38(95%CI 1.16-1.63,p<0.001)。
- 校正MSKCC术前和术后列线图后,AAM的BCR风险仍显著高于CM,HR分别为1.29(95%CI 1.08-1.53,p=0.004)和1.26(95%CI 1.05-1.49,p<0.001)。
- 校正CAPRA和CAPRA-S后,AAM的BCR风险有升高趋势但未达统计学显著,HR分别为1.13(95%CI 0.95-1.35,p=0.17)和1.11(95%CI 0.93-1.32,p=0.25)。
核心结论
- 这项大型多中心队列分析进一步提供证据表明,AAM在根治性前列腺切除术后可能具有比CAPRA和MSKCC列线图预测更高的BCR和AP发生率。
- 据此,AAM可能受益于更密切的术后监测,并可能更可能需要挽救性治疗。
研究设计与样本
- 回顾性综述宾夕法尼亚泌尿区域协作组2015至2021年间接受根治性前列腺切除术的男性。
- BCR分析纳入3190名符合入选标准的男性,AP分析纳入5029名符合入选标准的男性。
- 使用Cox比例风险回归模型比较术后BCR率,使用逻辑回归模型比较术后AP率,并校正CAPRA、CAPRA-S及MSKCC术前和术后列线图评分。
主要发现
- AAM的2年无BCR生存率为72.5%,CM为79.0%,HR为1.38(95%CI 1.16-1.63,p<0.001)。
- 校正MSKCC术前列线图后,AAM的BCR率显著高于CM,HR为1.29(95%CI 1.08-1.53,p=0.004)。
- 校正MSKCC术后列线图后,AAM的BCR率显著高于CM,HR为1.26(95%CI 1.05-1.49,p<0.001)。
- 校正CAPRA后,AAM的BCR率有升高趋势但未达统计学显著,HR为1.13(95%CI 0.95-1.35,p=0.17)。
- 校正CAPRA-S后,AAM的BCR率有升高趋势但未达统计学显著,HR为1.11(95%CI 0.93-1.32,p=0.25)。
临床怎么用
- 作者认为,AAM可能受益于更密切的术后监测,并可能更可能需要挽救性治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aims to determine if there is a difference in prostate cancer nomogram-adjusted risk of biochemical recurrence (BCR) and/or adverse pathology (AP) between African American (AAM) and Caucasian men (CM) undergoing radical prostatectomy (RP). METHODS: A retrospective review was performed of men undergoing RP in the Pennsylvania Urologic Regional Collaborative between 2015 and 2021. Cox proportional hazard regression models were used to compare the rate of BCR after RP, and logistic regression models were used to compare rates of AP after RP between CM and AAM, adjusting for the CAPRA, CAPRA-S, and MSKCC pre- and post-operative nomogram scores. RESULTS: Rates of BCR and AP after RP were analyzed from 3190 and 5029 men meeting inclusion criteria, respectively. The 2-year BCR-free survival was lower in AAM (72.5%) compared to CM (79.0%), with a hazard ratio (HR) of 1.38 (95% CI 1.16-1.63, p < 0.001). The rate of BCR was significantly greater in AAM compared to CM after adjustment for MSKCC pre-op (HR 1.29; 95% CI 1.08-1.53; p = 0.004), and post-op nomograms (HR 1.26; 95% CI 1.05-1.49; p < 0.001). There was a trend toward higher BCR rates among AAM after adjustment for CAPRA (HR 1.13; 95% CI 0.95-1.35; p = 0.17) and CAPRA-S nomograms (HR 1.11; 95% 0.93-1.32; p = 0.25), which did not reach statistical significance. The rate of AP was significantly greater in AAM compared to CM after adjusting for CAPRA (OR 1.28; 95% CI 1.10-1.50; p = 0.001) and MSKCC nomograms (OR 1.23; 95% CI 1.06-1.43; p = 0.007). CONCLUSION: This analysis of a large multicenter cohort provides further evidence that AAM may have higher rates of BCR and AP after RP than is predicted by CAPRA and MSKCC nomograms. Accordingly, AAM may benefit with closer post-operative surveillance and may be more likely to require salvage therapies.
引用
- Epstein M, Syed K, Danella J, et al. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men. Prostate Cancer Prostatic Dis. 2023. PMID: 37821578. doi:10.1038/s41391-023-00727-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。